Answers are grounded in this paper and cite their sources.
Naegleria fowleri causes primary amoebic meningoencephalitis (PAM), a rapidly progressing and highly fatal disease. Early diagnosis is critical for improving patient outcomes; however, current diagnostic methods remain limited in accessibility and practicality. This study aimed to evaluate the potential of an antibody-based approach for detecting N. fowleri . A polyclonal peptide antibody targeting the fowlerpain-2 protein of N. fowleri was generated. Antibody reactivity and specificity were evaluated using enzyme-linked immunosorbent assay and western blot analysis. Immunocytochemistry was performed in monoculture and co-culture systems with human brain cells. An in vivo PAM mouse model was established via intranasal infection, followed by immunohistochemical analysis of brain tissues and immunocytochemical analysis of nasal lavage fluid. The fowlerpain-2 antibody specifically detected N. fowleri in vitro and showed no reactivity with human cells in co-culture. In the PAM mouse model, the antibody enabled detection of N. fowleri in infected brain tissues. In addition, N. fowleri was detected in nasal lavage fluid, supporting its applicability to non-invasive sample types. These findings demonstrate that a fowlerpain-2-targeted antibody enables detection of N. fowleri in both in vitro and in vivo models. This approach may provide a basis for further development of antibody-based methods for detecting N. fowleri .
No takes yet. Share an insight, caveat, or question.
Jo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: